Chengxian Yang Selected Research

Chengxian Yang Research Topics

5	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 03/2017
4	Neoplasms (Cancer) 01/2022 - 03/2017
1	Parkinson Disease (Parkinson's Disease) 05/2024
1	Disease Progression 01/2024
1	Carcinogenesis 01/2022
1	Growth Hormone-Secreting Pituitary Adenoma 01/2022
1	Pituitary Apoplexy 01/2021
1	Hemorrhage 01/2021
1	Hypopituitarism (Sheehan's Syndrome) 01/2021
1	Hyponatremia 01/2021
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2020
1	Adenoma (Adenomas) 01/2020
1	Gigantism 01/2020
1	Ischemic Stroke 01/2020
1	Acromegaly 10/2019
1	Suppuration 11/2018
1	Polyuria 06/2018
1	Autoimmune Hypophysitis 06/2018
1	Polydipsia 06/2018
1	Headache (Headaches) 06/2018
1	Neoplasm Metastasis (Metastasis) 01/2018

2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
2	MethyltransferasesIBA 01/2022 - 03/2017
2	Hormones (Hormone)IBA 01/2022 - 01/2021
1	Therapeutic UsesIBA 05/2024
1	N-methyladenosineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	SodiumIBA 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2020
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	SteroidsIBA 06/2018
1	Mediator ComplexIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	EndopeptidasesIBA 01/2018
1	ZincIBA 01/2018
1	beta CateninIBA 01/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 09/2017
1	Bromocriptine (Parlodel)FDA LinkGeneric 09/2017